Literature DB >> 2863388

Mechanisms in cardiomyopathies.

J F Goodwin.   

Abstract

The three main clinical types of cardiomyopathy are: hypertrophic cardiomyopathy; dilated cardiomyopathy; and restrictive cardiomyopathy. In each case the basic cellular mechanisms still remain to be defined.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2863388     DOI： 10.1016/0022-2828(85)90003-3

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN： 0022-2828            Impact factor:   5.000


  6 in total

Review 1.  The pathogenesis of endomyocardial fibrosis: the role of the eosinophil.

Authors:  C J Spry
Journal:  Springer Semin Immunopathol       Date:  1989

2.  Classification of hypertrophied hearts in essential hypertension: evaluation by left ventricular wall stress and adrenergic responses.

Authors:  Y Sugishita; K Iida; K Yukisada; I Ito
Journal:  Br Heart J       Date:  1988-02

3.  Mapping of a functional autoimmune epitope on the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy.

Authors:  Y Magnusson; S Marullo; S Hoyer; F Waagstein; B Andersson; A Vahlne; J G Guillet; A D Strosberg; A Hjalmarson; J Hoebeke
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

4.  Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy.

Authors:  L X Fu; Y Magnusson; C H Bergh; J A Liljeqvist; F Waagstein; A Hjalmarson; J Hoebeke
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

5.  Extracellular matrix remodelling after coxsackievirus B3-induced murine myocarditis.

Authors:  R M Gómez; C G Castagnino; M I Berría
Journal:  Int J Exp Pathol       Date:  1992-10       Impact factor: 1.925

6.  Molecular mimicry between the immunodominant ribosomal protein P0 of Trypanosoma cruzi and a functional epitope on the human beta 1-adrenergic receptor.

Authors:  I Ferrari; M J Levin; G Wallukat; R Elies; D Lebesgue; P Chiale; M Elizari; M Rosenbaum; J Hoebeke
Journal:  J Exp Med       Date:  1995-07-01       Impact factor: 14.307
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.